print PRINT

SCIENCE > Health

Doctors’ group warns against hasty approval of Avigan for COVID-19 treatment

  • May 19, 2020
  • , Mainichi evening edition
  • JMH Summary

Tuesday evening’s Mainichi reported that a Japan Medical Association (JMA) panel released a statement earlier in the day calling for the Health Ministry to move very carefully when approving new drugs for the novel coronavirus. With Prime Minister Abe’s eagerness to use the flu drug Avigan to treat COVID-19 apparently in mind, the group recommended against the hasty approval of new medicines. “Approval that is not based on science could end up undermining public health,” the statement read, underscoring that an emergency must not be used to justify circumvention of requirements for clinical studies.

  • Ambassador
  • Ukraine
  • OPINION POLLS
  • COVID-19
  • Trending Japan